A collagen-based amniotic membrane scaffold combined with photobiomodulation accelerates wound repair in diabetic rats through modulation of inflammation and tissue regeneration
{"title":"A collagen-based amniotic membrane scaffold combined with photobiomodulation accelerates wound repair in diabetic rats through modulation of inflammation and tissue regeneration","authors":"Ahmed Hjazi","doi":"10.1016/j.tice.2025.103063","DOIUrl":null,"url":null,"abstract":"<div><div>Chronic diabetic wounds present significant challenges to effective tissue repair due to persistent inflammation and impaired regeneration. In this study, we investigated the therapeutic potential of a bioengineered collagen scaffold derived from the human amniotic membrane (CSAM), used alone or in combination with photobiomodulation therapy (PBMT), in a diabetic rat wound model. Forty diabetic rats were allocated into four groups: control, CSAM, PBMT, and CSAM+PBMT. Wound healing was assessed on days 4 and 8 post-injury. Combined treatment (CSAM+PBMT) significantly enhanced wound closure and histological regeneration, with notable increases in fibroblast and blood vessel density, epidermal and dermal thickness, collagen deposition, and expression levels of VEGF and bFGF compared to other groups. Additionally, this group exhibited a marked reduction in neutrophil infiltration and pro-inflammatory cytokines, including IL-1β, TNF-α, and NF-κB. These results demonstrate that the synergistic application of PBMT and CSAM fosters a pro-regenerative wound microenvironment by suppressing inflammation and promoting cellular proliferation and extracellular matrix remodeling. This combinatory approach offers a promising therapeutic avenue for improving diabetic wound healing outcomes.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"97 ","pages":"Article 103063"},"PeriodicalIF":2.5000,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tissue & cell","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S004081662500343X","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANATOMY & MORPHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Chronic diabetic wounds present significant challenges to effective tissue repair due to persistent inflammation and impaired regeneration. In this study, we investigated the therapeutic potential of a bioengineered collagen scaffold derived from the human amniotic membrane (CSAM), used alone or in combination with photobiomodulation therapy (PBMT), in a diabetic rat wound model. Forty diabetic rats were allocated into four groups: control, CSAM, PBMT, and CSAM+PBMT. Wound healing was assessed on days 4 and 8 post-injury. Combined treatment (CSAM+PBMT) significantly enhanced wound closure and histological regeneration, with notable increases in fibroblast and blood vessel density, epidermal and dermal thickness, collagen deposition, and expression levels of VEGF and bFGF compared to other groups. Additionally, this group exhibited a marked reduction in neutrophil infiltration and pro-inflammatory cytokines, including IL-1β, TNF-α, and NF-κB. These results demonstrate that the synergistic application of PBMT and CSAM fosters a pro-regenerative wound microenvironment by suppressing inflammation and promoting cellular proliferation and extracellular matrix remodeling. This combinatory approach offers a promising therapeutic avenue for improving diabetic wound healing outcomes.
期刊介绍:
Tissue and Cell is devoted to original research on the organization of cells, subcellular and extracellular components at all levels, including the grouping and interrelations of cells in tissues and organs. The journal encourages submission of ultrastructural studies that provide novel insights into structure, function and physiology of cells and tissues, in health and disease. Bioengineering and stem cells studies focused on the description of morphological and/or histological data are also welcomed.
Studies investigating the effect of compounds and/or substances on structure of cells and tissues are generally outside the scope of this journal. For consideration, studies should contain a clear rationale on the use of (a) given substance(s), have a compelling morphological and structural focus and present novel incremental findings from previous literature.